ライフサイエンスコーパス: pneumococcal surface protein A

1 ory IgG responses to both phosphocholine and pneumococcal surface protein A.

2 ve to Ig responses to the cell wall protein, pneumococcal surface protein A.

3 ing the sequence for the antigenic region of pneumococcal surface protein A and demonstrated that mic

4 , which included 109 variants of the diverse pneumococcal surface proteins A and C (PspA and PspC) an

5 , the type 1 IgG isotype titers specific for pneumococcal surface protein A are reduced in MyD88(-/-)

6 against the pneumococcal surface components pneumococcal surface protein A family 2, pneumococcal su

7 PspA (pneumococcal surface protein A) is a serologically varie

8 ated that only S. pneumoniae lacking the CBP pneumococcal surface protein A lost its ability to inhib

9 Intranasal immunization of mice with PspA (pneumococcal surface protein A) or a capsular 6B polysac

10 , pyruvate oxidase (SpxB), autolysin (LytA), pneumococcal surface protein A, or neuraminidase A (NanA

11 response to a soluble conjugate of PPS14 and pneumococcal surface protein A (PspA) (PPS14-PspA) in sa

12 occus pneumoniae (strain R36A), specific for pneumococcal surface protein A (PspA) and for the phosph

13 Immunization i.n. with pneumococcal surface protein A (PspA) and IL-12 resulted

14 iations of the virulence-associated proteins pneumococcal surface protein A (PspA) and pneumococcal c

15 fferent antigens, the alpha-helix domains of pneumococcal surface protein A (PspA) and pneumococcal s

16 vaccines were examined for contamination by pneumococcal surface protein A (PspA) and pneumococcal s

17 Pneumococcal surface protein A (PspA) and PspC are impor

18 Pneumococcal surface protein A (PspA) and PspC of Strept

19 This study used mutants lacking pneumococcal surface protein A (PspA) and PspC to demons

20 ccus pneumoniae capsular polysaccharides and pneumococcal surface protein A (PspA) are major determin

21 Pneumococcal surface protein A (PspA) can elicit protect

22 Pneumococcal surface protein A (PspA) efficiently inhibi

23 otein A (PpmA), and the N-terminal region of pneumococcal surface protein A (PspA) from S. pneumoniae

24 Immunization with pneumococcal surface protein A (PspA) from Streptococcus

25 Pneumococcal surface protein A (PspA) has been shown to

26 Antibody to pneumococcal surface protein A (PspA) has been shown to

27 Pneumococcal surface protein A (PspA) is a highly immuno

28 Pneumococcal surface protein A (PspA) is a pneumococcal

29 Pneumococcal surface protein A (PspA) is a serologically

30 Pneumococcal surface protein A (PspA) is a surface-expos

31 Pneumococcal surface protein A (PspA) is able to elicit

32 Pneumococcal surface protein A (PspA) is an immunogenic

33 Pneumococcal surface protein A (PspA) is an immunogenic

34 Pneumococcal surface protein A (PspA) is an important vi

35 Pneumococcal surface protein A (PspA) is highly immunoge

36 In this study, we demonstrated that pneumococcal surface protein A (PspA) nasally administer

37 mmunization with recombinant forms of either pneumococcal surface protein A (PspA) or PdB (a genetica

38 chemical immunosensor for rapid detection of pneumococcal surface protein A (PspA) peptide and SP lys

39 Antimicrobial susceptibility, pneumococcal surface protein A (PspA) serotyping, and pu

40 , and presented S. pneumoniae or recombinant pneumococcal surface protein A (PspA) to a PspA-specific

41 secreted form of the alpha-helical region of pneumococcal surface protein A (PspA) to the mouse immun

42 ch has maintained two different types of the pneumococcal surface protein A (PspA) virulence factor a

43 mbinant Salmonella vaccine strain expressing pneumococcal surface protein A (PspA) was developed.

44 result of the absence of choline in the LTA, pneumococcal surface protein A (PspA) was no longer reta

45 date Salmonella vaccine strains synthesizing pneumococcal surface protein A (PspA) were also confirme

46 model of intact bacteria in which PPS14 and pneumococcal surface protein A (PspA) were stably attach

47 of pFL and CpG ODN as a nasal adjuvant for a pneumococcal surface protein A (PspA) would enhance PspA

48 Pneumococcal surface protein A (PspA), a cross-reactive

49 In that regard, pneumococcal surface protein A (PspA), a major surface p

50 Pneumococcal surface protein A (PspA), a major virulence

51 Pneumococcal surface protein A (PspA), a virulence facto

52 onal antibody and antibodies to pneumolysin, pneumococcal surface protein A (PspA), and pneumococcal

53 response specific for the cell wall protein, pneumococcal surface protein A (PspA), as well as in the

54 These vaccine candidates included pneumococcal surface protein A (PspA), choline binding p

55 al histidine triad proteins (PhtD and PhtE), pneumococcal surface protein A (PspA), plasminogen and f

56 fied the previously characterized immunogens pneumococcal surface protein A (PspA), putative proteina

57 , pneumococcal surface adhesin A (PsaA), and pneumococcal surface protein A (PspA)-are currently bein

58 ether secretory-IgA (S-IgA) Abs induced by a pneumococcal surface protein A (PspA)-based nasal vaccin

59 IgG2b > IgG3) were significantly higher than pneumococcal surface protein A (PspA)-specific, genetic

60 22)] was linked in a fusion protein with the pneumococcal surface protein A (PspA).

61 polysaccharide (cps), pneumolysin (ply), and pneumococcal surface protein A (pspA).

62 rrin is bound to the pneumococcal surface by pneumococcal surface protein A (PspA).

63 C-polysaccharide, and the cell wall protein, pneumococcal surface protein A (PspA).

64 dentified it as the NH(2)-terminal region of pneumococcal surface protein A (PspA).

65 ing the sequence for the antigenic region of pneumococcal surface protein A (PspA).

66 novel virulence factors of S. pneumoniae is pneumococcal surface protein A (PspA).

67 ine (PC) determinant of C-polysaccharide and pneumococcal surface protein A (PspA).

68 il pool sizes on humoral memory responses to pneumococcal surface protein A (PspA).

69 nts with a disruption in the gene for either pneumococcal surface protein A (PspA-), neuraminidase A

70 y demonstrated that both an in vivo protein (pneumococcal surface protein A [PspA])- and polysacchari

71 ble PS and protein Ags, the anti-PC and anti-pneumococcal surface protein A responses differed in tha

72 ild-type (WT) (0%) littermates and had lower pneumococcal surface protein A-specific Ab titers when i

73 antibody directed against the whole cell and pneumococcal surface protein A than control subjects.

74 ghly antigenic alpha-helical region of PspA (pneumococcal surface protein A) was subcloned downstream